You have 9 free searches left this month | for more free features.

alt-801

Showing 1 - 10 of 10

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Type 2 Diabetes Trial (ALT-801, Placebo)

Active, not recruiting
  • Type 2 Diabetes
  • ALT-801
  • Placebo
  • Fort Myers, Florida
  • +6 more
Oct 11, 2022

Non-Alcoholic Fatty Liver Disease Trial in United States (ALT-801, Placebo)

Active, not recruiting
  • Non-Alcoholic Fatty Liver Disease
  • ALT-801
  • Placebo
  • Montclair, California
  • +12 more
Oct 11, 2022

NASH - Nonalcoholic Steatohepatitis Trial in Herston (ALT-801, Placebo)

Completed
  • NASH - Nonalcoholic Steatohepatitis
  • ALT-801
  • Placebo
  • Herston, Queensland, Australia
    Nucleus Networks
Nov 8, 2021

NASH - Nonalcoholic Steatohepatitis Trial in Herston, Adelaide (ALT-801, Metformin, Atorvastatin)

Recruiting
  • NASH - Nonalcoholic Steatohepatitis
  • ALT-801
  • +5 more
  • Herston, Queensland, Australia
  • +1 more
Nov 8, 2021

Non-Alcoholic Fatty Liver Disease Trial in United States (ALT-801, Placebo)

Active, not recruiting
  • Non-Alcoholic Fatty Liver Disease
  • ALT-801
  • Placebo
  • Scottsdale, Arizona
  • +14 more
Jun 30, 2022

Obesity/Overweight Trial in Los Angeles, Indianapolis (ALT-801, Placebo)

Active, not recruiting
  • Obesity/Overweight
  • ALT-801
  • Placebo
  • Birmingham, Alabama
  • +30 more
Sep 7, 2022

Non-muscle Invasive Bladder Cancer Trial in United States (ALT-801, Gemcitabine)

Unknown status
  • Non-muscle Invasive Bladder Cancer
  • Birmingham, Alabama
  • +4 more
Jan 23, 2017

Metastatic Melanoma Trial in United States (Cisplatin, ALT-801)

Completed
  • Metastatic Melanoma
  • Los Angeles, California
  • +7 more
Oct 26, 2016

Transitional Cell Carcinoma of Bladder, Urethra Cancer, Ureter Cancer Trial in United States (Cisplatin, Gemcitabine, ALT-801)

Unknown status
  • Transitional Cell Carcinoma of Bladder
  • +3 more
  • Tucson, Arizona
  • +15 more
Apr 11, 2016

Acute Myeloid Leukemia Trial in Houston (G-CSF, Cytarabine, Fludarabine)

Withdrawn
  • Acute Myeloid Leukemia
  • Houston, Texas
    MD Anderson Cancer Center
Jan 2, 2014